The ROE as of November 2024 (TTM) for Tango Therapeutics, Inc. (TNGX) is -49.64%

According to Tango Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -49.64%. This represents a change of 300.82% compared to the average of -12.38% of the last 4 quarters.

Tango Therapeutics, Inc. (TNGX) Historical ROE (quarterly & annually)

How has TNGX ROE performed in the past?

The mean historical ROE of Tango Therapeutics, Inc. over the last ten years is -82.62%. The current -49.64% ROE has changed -39.93% with respect to the historical average. Over the past ten years (40 quarters), TNGX's ROE was at its highest in in the June 2021 quarter at -2.78%. The ROE was at its lowest in in the June 2020 quarter at -34213.96%.

Tango Therapeutics, Inc. (TNGX) ROE by Quarter and Year

Discovering the peaks and valleys of Tango Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tango Therapeutics, Inc. (TNGX) Average ROE

How has TNGX ROE performed in the past?

The current ROE of Tango Therapeutics, Inc. (TNGX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Tango Therapeutics, Inc. (TNGX) ROE vs. Peers

How is TNGX’s ROE compared to its peers?

Tango Therapeutics, Inc.’s ROE is greater than Third Harmonic Bio, Inc. (-4.28%), greater than Cullinan Oncology, Inc. (-26.54%), greater than Edgewise Therapeutics, Inc. (-26.83%), greater than Rallybio Corporation (-77.39%), greater than Monte Rosa Therapeutics, Inc. (-62.68%), less than Connect Biopharma Holdings Limited (7.21%), greater than Tyra Biosciences, Inc. (-25.14%), greater than RAPT Therapeutics, Inc. (-89.09%), greater than Xilio Therapeutics, Inc. (-214.74%), greater than Mineralys Therapeutics, Inc. (-55.92%), less than Foghorn Therapeutics Inc. (167.93%), greater than Shattuck Labs, Inc. (-61.92%), greater than Kymera Therapeutics, Inc. (-24.96%), greater than Nurix Therapeutics, Inc. (-63.39%), greater than TCR2 Therapeutics Inc. (-71.90%), greater than Revolution Medicines, Inc. (-33.67%), greater than Black Diamond Therapeutics, Inc. (-68.08%), greater than Atreca, Inc. (-199.88%), greater than Passage Bio, Inc. (-72.53%), greater than Relay Therapeutics, Inc. (-45.75%), greater than Stoke Therapeutics, Inc. (-54.45%), greater than Pliant Therapeutics, Inc. (-48.91%), greater than Arvinas, Inc. (-50.26%),

Build a custom stock screener for Tango Therapeutics, Inc. (TNGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tango Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tango Therapeutics, Inc. (TNGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tango Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.